Member Info for Bazzaman

Enjoy Barcelona on the 8th. Hoping the shares hold up during the summer whilst I'm in Crete.

I've looked at SMP a few times on other peoples recommendations that they are a good long term hold. I don't have any myself as I already have a couple of good long term holds. I wouldn't put you off as I know there are a lot of fans for this share. BOL.

FinnCap reiterates buy & raises target price from 137.5 to 152.

1. Profit taking buy on rumour sell on fact. 2. Grexit 3. CEO leaving 4. MMs wanting the shares for themselves 5. who knows? I would expect this to recover & move on upwards towards a new target price beyond 140 IMO

They have almost achieved the underlying profit levels that brokers were expecting in 2016 not 2015. Also top of the range dividend estimates were 1.9p & they are 2.1p so expect another uplift in SP today. The only negative is the retirement of the CEO but at least he is staying on as an advisory role until June 2016, good hand holding policy there. GLA.

"The impressive results in 2015 are stronger than originally expected. They reflect the operational improvements implemented by management over recent years which are now delivering growth in both revenue and profitability, together with the upturn in confidence as we progressed through the year. There are some macroeconomic influences that we cannot control which may affect future results. This being said, as a business we remain confident in our ability to deliver our strategy and are excited about the future. At this early stage of the year, the forward order book remains solid and the Group's trading performance has been good as it continues to benefit from the positive momentum witnessed in the second half of last year. There continue to be many opportunities, both across our key sectors and with new and existing customer partnerships, and we believe that the Group will go from strength to strength. We remain encouraged by the future growth profile of the business and our commercial progress looks set to continue positively during 2015/16." Wow, I'm happy with these record results & dividend up 50%.

I topped up on Friday, always good to average up on a rising share.

Cant wait, expecting great news tomorrow.

Patience & a cool head will be well rewarded with this share but as Volcano says you could also make short term profits & buy on the dips (if there are any of course). BOL.

I'm in for the long haul with this one, could easily be 225 to 250 this time next year if fundamentals continue in the same way. Looking to double or treble my returns within 3 years. DYOR though as only my opinion. A great company IMO.

trading update should be interesting as a reminder from the May results outlook; The last quarter of the period saw record performances from UL Medicines, Biodose® and Quantum Aseptic Services and I am pleased to report that these record performances were subsequently beaten in the first quarter of the current financial year. The Colonis pipeline has nearly doubled in the five months since Admission to approximately 60 products through a combination of new developments started by Colonis and existing developments at Lamda at the time of acquisition. We expect to see further growth in the coming months and years as the Group continues to expand its target markets and successfully launches more products and services. The Group continues to trade in line with management's expectations. I believe that the outlook for Quantum Pharma is exciting. During the current financial year, we will continue to lay strong foundations for future growth. The Group has a very strong pipeline of niche pharmaceutical products which, coupled with a market-leading service, will provide significant opportunities both in the UK and internationally.

Not been to Barcelona..........yet! Hopefully some time next year. I'm off to Crete in July for 2 week summer vacation - plenty of sun there. TW is on a roll.

What's your exit price or are you staying for the long run?

on up ahead of results next week.

I topped up once more in Quantum Pharma (QP.) as I do like to average up in the good ones. It reported a decent set of results last week and shares have been motoring since with big profits coming in which is great as I'm building quite a stake in it. The Mail on Sunday also tipped it in the last edition with a good write up which you should be able to find online. I've averaged up again as I think there is still some very decent upside with, given time, perhaps a lot more. 

An overdue word on AMINO TECHNOLOGIES, which has been an often commented subject here, where I also have an interest in the shares. Amino has been a good performer for me, although like others I have often aired my own thoughts on just what the company might do with its bulging cash pile.   While it has often been suggested by some that a one-off extra dividend would be paid, it was not a message that CEO Donald McGarva conveyed to me in the past. While that notion was effectively dismissed outright, potential acquisitions by contrast were not, although McGarva had stated it would very much have to be the right fit.     So, having duly announced just a few weeks back that it was acquiring Finland based Booxmedia for an initial 7.9m Euro’s, one can perhaps conclude that it is a strategically sound move.   Booxmedia will add a platform to the wider Amino business that will allow it to expand into new areas of media and entertainment which will include mobile operators, media companies and various broadcasters.   While that announcement came last month, just last week Amino has delivered a positive Trading Update to the market, which has seen the share price nudge up to £1.43p.   The company stated that it anticipates a return to revenue growth in the first half of the year to May, although as is usual with Amino it expects a second half weighting. Although such wording can, as I have often mentioned before be a prelude to a subsequent warning, It is a familiar theme with the Cambridge based business, so it isn’t something that I am concerned with.   Indeed the company added that it is confident of meeting market expectations for the full year. Additionally, the interim dividend is being increased to 1.26p against the previous 1.15p continuing a progressive theme. With further progress being made in the familiar trading regions of N. America and Western Europe, Amino added that it was also enjoying momentum within Africa and the Middle East.    The company has really come good over the last couple of years where as I said at the outset the shares have been a solid performer for me. However, there appears to be some decent momentum and drive within the company where its profile now looks set for a further boost with the appointment of Canaccord Genuity as joint Broker With FinnCap.   I shall endeavour to take a view at its opening note where currently FinnCap has pre-tax profits of £4.8m lined up for next year and EPS of 9p. The forward PER of 15 looks worthy of ongoing consideration to me, given the continued strong net cash position and a growing dividend.  

Profit taking as this has moved a fair bit over the past 2 weeks.

Simon raises his target price to 110. http://www.investorschronicle.co.uk/2015/06/02/comment/simon-thompson/hitting-target-prices-GnO28Ac2eqovUnvH4hidnJ/article.html

Great tip in Midas today - http://www.dailymail.co.uk/money/investing/article-3103785/MIDAS-SHARE-TIPS-Quantum-Pharmaceutical-devises-prompts-people-medicine-alerts-carers-need-arises.html

Why do you think that? Have a great weekend.